How many shares of CLDX does BNP PARIBAS FINANCIAL MARKETS own?

As of 2026-Q2, BNP PARIBAS FINANCIAL MARKETS holds 31,191 shares of CLDX (Celldex Therapeutics, Inc.).

What is BNP PARIBAS FINANCIAL MARKETS's CLDX position worth?

As of 2026-Q2, BNP PARIBAS FINANCIAL MARKETS's CLDX position is worth $1.2M.

Is BNP PARIBAS FINANCIAL MARKETS buying or selling CLDX?

In 2026-Q2, BNP PARIBAS FINANCIAL MARKETS decreased their CLDX position (-82.3% change in shares).

When did BNP PARIBAS FINANCIAL MARKETS first buy CLDX?

Based on available 13F filings, BNP PARIBAS FINANCIAL MARKETS first reported a position in CLDX in 2018-Q4. They have held the position across 31 quarters.

Back to

BNP PARIBAS FINANCIAL MARKETS

CLDX
31 quarters

Position history for BNP PARIBAS FINANCIAL MARKETS's holdings in Celldex Therapeutics, Inc.

Current Value

$1.2M

Current Shares

31,191

Total Value Change

+$1.2M

Total Shares Change

+27,369

Quarter-by-Quarter History

Quarter	Action	Shares	Change	Value	Weight	Price	Conviction
2026-Q2 Latest	Decreased	31,191	-82.3%	$1.2M	0.0%	$37.21	0
2026-Q1	Decreased	175,788	-23.8%	$5.6M	0.0%	$28.94	0
2025-Q4	Increased	230,662	+72.3%	$6.3M	0.0%	$26.43	41
2025-Q3	Decreased	133,883	-36.6%	$3.5M	0.0%	$26.19	0
2025-Q2	Increased	211,260	+100.9%	$4.3M	0.0%	$20.29	43
2025-Q1	Increased	105,140	+67.9%	$1.9M	0.0%	$19.93	38
2024-Q4	Increased	62,631	+122.3%	$1.6M	0.0%	$25.12	41
2024-Q3	Increased	28,181	+293.1%	$957,872	0.0%	$33.20	40
2024-Q2	Decreased	7,168	-87.2%	$265,288	0.0%	$37.01	0
2024-Q1	Decreased	56,044	-59.0%	$2.4M	0.0%	$41.97	0
2023-Q4	Increased	136,601	+48.9%	$5.4M	0.0%	$39.66	37
2023-Q3	Increased	91,723	+80.7%	$2.5M	0.0%	$27.52	40
2023-Q2	Decreased	50,757	-44.6%	$1.7M	0.0%	$34.58	0
2023-Q1	Increased	91,583	+155.4%	$3.3M	0.0%	$35.58	43
2022-Q4	Decreased	35,862	-52.0%	$1.6M	0.0%	$44.57	0
2022-Q3	Increased	74,771	+654.8%	$2.1M	0.0%	$28.35	42
2022-Q2	Increased	9,906	+162.0%	$267,066	0.0%	$27.83	37
2022-Q1	Decreased	3,781	-74.1%	$128,781	0.0%	$34.59	0
2021-Q4	Increased	14,590	+69.3%	$563,758	0.0%	$38.90	36
2021-Q3	Increased	8,620	+470.9%	$465.4M	0.0%	$51.97	50
2021-Q2	Increased	1,510	+370.4%	$50,494	0.0%	$35.37	33
2021-Q1	Increased	321	+106x	$6,613	0.0%	$19.73	17
2020-Q4	Unchanged	3	0.0%	$53	0.0%	$17.88	0
2020-Q3	Unchanged	3	0.0%	$44	0.0%	$15.19	0
2020-Q2	Decreased	3	-87.5%	$39	0.0%	$12.48	0
2020-Q1	Unchanged	24	0.0%	$40	0.0%	$1.77	0
2019-Q4	Decreased	24	-90.6%	$54	0.0%	$2.20	0
2019-Q3	Decreased	256	-6.6%	$545	0.0%	$2.17	0
2019-Q2	New	274	-	$734	0.0%	$2.68	17
2019-Q1	Exited	0	-100.0%	$0	0.0%	$4.92	0
2018-Q4	New	3,822	-	$756	0.0%	$3.00	17

Other major holders of CLDX: WELLINGTON MANAGEMENT GROUP LLP

CLDX31 quarters

CLDX
31 quarters